CoChat

Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents

Open access
Yasser Khalil Bustanji, Ala Issa, Mohammad Mohammad, Mohammad Hudaib, Khalid Tawah, Hatim S. AlKhatib, Ihab M. Almasri, Bashar A. Alkhalidi · 2010 · Journal of Medicinal Plants Research
Cited by 124

The DOI matches its OpenAlex record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Rosmarinus officinalis L. (Rosemary) has been long claimed to have hypogylcemic-hypolipidemic dual effects in folkloric medicine. In an effort to explain rosemary's claimed benefits, numerous published studies have investigated an array of pharmacologic activities of the plant including anti-inflammatory, anticarcinogenic and metabolic effects. The question remained, however, as how rosemary would target both plasma lipids and glucose levels simultaneously. A newer mechanism has been suggested, in which targeting the hormone sensitive lipase (HSL) would be the common link between the two metabolic effects. In fact, HSL has been extensively studied for its effects on the metabolic switch between glucose and free fatty acids (FFAs) as an energy source. The current manuscript summarizes a significant amount of work that was undertaken to identify plant species native to Jordan with potential HSL and pancreatic lipase (PL) inhibitory activities. Our results demonstrated in vitroinhibitory effects of R. officnalis on both HSL and PL in a dose dependent manner. Interestingly, the rosemary extract had an IC50 for PL that was several fold lower than the IC50 for HSL, indicating a higher affinity to the former enzyme (13.8 and 95.2 μg/mL for PL and HSL, respectively). In addition, we have compared the inhibitory activities of purified constituents found in rosemary to the parent plant [rosmarinic acid (RA), chlorogenic acid (CA), caffeic acid (CaA) and gallic acid (GA)]. Our results showed that all the tested compounds (RA, CA, CaA, and GA) were able to inhibit the PL and HSL activities in a dose dependent manner, but with different potencies. PL and HSL IC50 values were calculated for each compound and GA was found to be the most potent (IC50 10.1 and 14.5 for PL and HSL, respectively). Further work is necessary to determine whether our in vitro findings would correlate with the in vivo effects. Nonetheless, our results are a first step in fully understanding the long claimed hypoglycemic-hypolipidemic dual effects of rosemary. Simultaneous targeting of both HSL and PL is likely to open the door for a new era in our continuous battle against DM type 2 and its cardiovascular complications. Currently, we are working on identifying the most active constituents of the plant to evaluate a structure-activity relationship which would pave the road for future therapeutic use. Key words: Rosmarinus officinalis, Rosemary, obesity, diabetes mellitus, pancreatic lipase, hormone sensitive lipase, phenolic compounds, rosmarinic acid.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.5897/jmpr10.399

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Bustanji, Y. K., Issa, A., Mohammad, M., Hudaib, M., Tawah, K., AlKhatib, H. S., Almasri, I. M., & Alkhalidi, B. A.
Venue
Journal of Medicinal Plants Research
Publisher
Academic Journals
Published
2010-11-04
Volume
4
Issue
21
Pages
2235-2242
ISSN
1996-0875 (ISSN-L)
OpenAlex
W2138898558
Cited by
124
References
5
FWCI
2.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.